Cassava Sciences
SAVA
#9287
Rank
C$0.15 B
Marketcap
C$3.23
Share price
12.26%
Change (1 day)
45.32%
Change (1 year)

Earnings for Cassava Sciences (SAVA)

Earnings in 2025 (TTM): -C$0.16 Billion

According to Cassava Sciences 's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -C$0.2 Billion a decrease over its 2023 earnings that were of -C$0.15 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Cassava Sciences from 2000 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -C$0.16 Billion-18.71%
2024 -C$0.2 Billion34.28%
2023 -C$0.15 Billion32.41%
2022 -C$0.11 Billion143.46%
2021 -C$44.67 Million383.92%
2020 -C$9.23 Million36.96%
2019 -C$6.74 Million-25.56%
2018 -C$9.06 Million-44.25%
2017 -C$16.24 Million-20.11%
2016 -C$20.33 Million5.32%
2015 -C$19.3 Million14.23%
2014 -C$16.9 Million-139.64%
2013 C$42.61 M
2010 -C$18.62 Million102.87%
2009 -C$9.18 Million-177.52%
2008 C$11.83 M-14.32%
2007 C$13.81 M-1942.21%
2006 -C$0.76 Million
2004 -C$52.95 Million75.1%
2003 -C$30.24 Million
2001 -C$23.53 Million20.49%
2000 -C$19.53 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
ORIC Pharmaceuticals
ORIC
-C$0.2 Billion 27.50%๐Ÿ‡บ๐Ÿ‡ธ USA